Home Neoplasma 2018 Neoplasma Vol.65, No.5, p.656-663, 2018

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.65, No.5, p.656-663, 2018

Title: Nicotinamide N-methyltransferase as a potential marker for cancer
Author: X.M. LU, H. LONG

Abstract: Cancer remains the main global cause of death despite noteworthy advances in cancer research over the past decades. Early detection is extremely important in improving successful therapy and further work is therefore urgently required to find novel tumor markers for treatment. Herein, we studied Nicotinamide N-methyltransferase (NNMT) which is a cytosolic enzyme that catalyzes the N-methylation of nicotinamide to form 1-methylnicotinamide (1-MNA). This plays an important role in controlling the intracellular concentration of nicotinamide, the precursor to NAD+ and an important cofactor which associates cellular redox states with energy metabolism. Growing evidence shows that NNMT protein levels are elevated in a variety of human cancers, and increased NNMT expression has been linked to tumor aggressiveness. This paper presents a review of the role of NNMT expression in a series of human cancers and the regulating mechanisms involved. We offer the potential value of NNMT in cancer detection and treatment.

Keywords: Nicotinamide N-methyltransferase (NNMT), cancer, 1-methylnicotinamide (1-MNA)
Published online: 24-Sep-2018
Year: 2018, Volume: 65, Issue: 5 Page From: 656, Page To: 663
doi:10.4149/neo_2018_171024N680
Price: 19.20 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.